These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23429371)

  • 1. H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas.
    Gielen GH; Gessi M; Hammes J; Kramm CM; Waha A; Pietsch T
    Am J Clin Pathol; 2013 Mar; 139(3):345-9. PubMed ID: 23429371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic Findings.
    Morris M; Driscoll M; Henson JW; Cobbs C; Jiang L; Gocke CD; Chen L; Rodriguez FJ
    J Neuropathol Exp Neurol; 2020 Oct; 79(10):1038-1043. PubMed ID: 32954438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric thalamic glioma with H3F3A K27M mutation, which was detected before and after malignant transformation: a case report.
    Ishibashi K; Inoue T; Fukushima H; Watanabe Y; Iwai Y; Sakamoto H; Yamasaki K; Hara J; Shofuda T; Kanematsu D; Yoshioka E; Kanemura Y
    Childs Nerv Syst; 2016 Dec; 32(12):2433-2438. PubMed ID: 27392443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas.
    Venneti S; Santi M; Felicella MM; Yarilin D; Phillips JJ; Sullivan LM; Martinez D; Perry A; Lewis PW; Thompson CB; Judkins AR
    Acta Neuropathol; 2014 Nov; 128(5):743-53. PubMed ID: 25200322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDH1 mutation in pediatric gliomas: has it a diagnostic and prognostic value?
    Buccoliero AM; Castiglione F; Degl'Innocenti DR; Gheri CF; Genitori L; Taddei GL
    Fetal Pediatr Pathol; 2012 Oct; 31(5):278-82. PubMed ID: 22432788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.
    Karremann M; Gielen GH; Hoffmann M; Wiese M; Colditz N; Warmuth-Metz M; Bison B; Claviez A; van Vuurden DG; von Bueren AO; Gessi M; Kühnle I; Hans VH; Benesch M; Sturm D; Kortmann RD; Waha A; Pietsch T; Kramm CM
    Neuro Oncol; 2018 Jan; 20(1):123-131. PubMed ID: 29016894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Analysis of Diffuse High-Grade Astrocytomas in Infancy Defines a Novel Molecular Entity.
    Gielen GH; Gessi M; Buttarelli FR; Baldi C; Hammes J; zur Muehlen A; Doerner E; Denkhaus D; Warmuth-Metz M; Giangaspero F; Lauriola L; von Bueren AO; Kramm CM; Waha A; Pietsch T
    Brain Pathol; 2015 Jul; 25(4):409-17. PubMed ID: 25231549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3F3A K27M mutations in thalamic gliomas from young adult patients.
    Aihara K; Mukasa A; Gotoh K; Saito K; Nagae G; Tsuji S; Tatsuno K; Yamamoto S; Takayanagi S; Narita Y; Shibui S; Aburatani H; Saito N
    Neuro Oncol; 2014 Jan; 16(1):140-6. PubMed ID: 24285547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of H3 K27M mutations in adult midline gliomas.
    Ebrahimi A; Skardelly M; Schuhmann MU; Ebinger M; Reuss D; Neumann M; Tabatabai G; Kohlhof-Meinecke P; Schittenhelm J
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):839-850. PubMed ID: 30610375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies.
    Oliveira VF; De Sousa GR; Dos Santos AC; Saggioro FP; Machado HR; de Oliveira RS; Tone LG; Valera ET
    Childs Nerv Syst; 2021 Feb; 37(2):375-382. PubMed ID: 32766947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the IDH1 codon 132 mutation in brain tumors.
    Balss J; Meyer J; Mueller W; Korshunov A; Hartmann C; von Deimling A
    Acta Neuropathol; 2008 Dec; 116(6):597-602. PubMed ID: 18985363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting the H3F3A mutant allele found in high-grade pediatric glioma by real-time PCR.
    Zhang R; Han J; Daniels D; Huang H; Zhang Z
    J Neurooncol; 2016 Jan; 126(1):27-36. PubMed ID: 26376656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tectal Low-Grade Glioma with H3 K27M Mutation.
    Sumi K; Shijo K; Igarashi T; Yamamuro S; Sasano M; Oshima H; Ishige T; Honma T; Yagasaki H; Yoshino A
    World Neurosurg; 2020 Sep; 141():91-100. PubMed ID: 32505657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of H3F3A (K27M) mutations characterizes pediatric and adult high-grade gliomas of the spinal cord.
    Gessi M; Gielen GH; Dreschmann V; Waha A; Pietsch T
    Acta Neuropathol; 2015 Sep; 130(3):435-7. PubMed ID: 26231952
    [No Abstract]   [Full Text] [Related]  

  • 16. Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.
    Pagès M; Beccaria K; Boddaert N; Saffroy R; Besnard A; Castel D; Fina F; Barets D; Barret E; Lacroix L; Bielle F; Andreiuolo F; Tauziède-Espariat A; Figarella-Branger D; Puget S; Grill J; Chrétien F; Varlet P
    Brain Pathol; 2018 Jan; 28(1):103-111. PubMed ID: 27984673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.
    Chai RC; Zhang YW; Liu YQ; Chang YZ; Pang B; Jiang T; Jia WQ; Wang YZ
    Acta Neuropathol Commun; 2020 Mar; 8(1):40. PubMed ID: 32228694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
    Parhar P; Ezer R; Shao Y; Allen JC; Miller DC; Newcomb EW
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):98-103. PubMed ID: 15950766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution.
    Yoshimoto K; Hatae R; Sangatsuda Y; Suzuki SO; Hata N; Akagi Y; Kuga D; Hideki M; Yamashita K; Togao O; Hiwatashi A; Iwaki T; Mizoguchi M; Iihara K
    Brain Tumor Pathol; 2017 Jul; 34(3):103-112. PubMed ID: 28447171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas.
    Venneti S; Garimella MT; Sullivan LM; Martinez D; Huse JT; Heguy A; Santi M; Thompson CB; Judkins AR
    Brain Pathol; 2013 Sep; 23(5):558-64. PubMed ID: 23414300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.